博士、博士后简历模板

博士、博士后简历 070623007 个 人 简 简 —————————————————————————————————姓名,XXX 性简,男出生年月,1950年1月15日学学简及位,博士、博士后 工作简位及简,称美国 M.D. Anderson 简瘤院及究所医研, 副主任简、副授医教 博士后简简 学学简、位, 1975 1978 –年天津科大简系本科生简简医学医 1980 1982–年天津科大泌尿外科简士生简简医学 1987 1991–年美布拉斯加大院简瘤简物国内学医学治简博士生简简学 1991 1993–年美堪简斯大院简瘤国学医学化简及生物治简博士后简简工作简简, 1978 1980–年天津市简瘤院化简及免疫治简医科住院简医 1982 1985–年天津科大第二附院泌尿外科医学属医住院简医 1985 1987–年美西北大院简瘤生物治简简简者国学医学学 1993 1997–年美哈佛大院国学医学 Dana-Farber 简瘤究所高简简床研研究简1997 –2003 年美布拉斯加大院附院简瘤科主治简、副主任简国内学医学属医医医、 博士后简简 2003 - 至今美德克简斯州休斯敦市国 M.D. Anderson 简瘤院及究所医研, 副主任简、副授、博士后简简医教 本人于1978 年简简于天津科大简系。后在医学医随天津市简瘤院化简及免疫治简医科任 住院医简。于1980 年考入天津科大第二院泌尿外科攻简泌尿外科简家简简简授医学医教简士究生研。 1985 年由天津科大第二院泌尿外科到美西北大简修简瘤生物治简简简。 又于 医学医国学1987 年考入美 国University of Nebraska Medical Center (布拉斯加大内学医学院) 攻简简瘤简物治简博士位。学学简简后于1991 年至1993 年在美堪简斯大中心简瘤国学医学化简及生物治简科做博士后究。研1993 年至1997 年在美哈佛大院国学医学 Dana-Farber 简瘤究所任研高简简床究简研～ 简简新抗癌简物的简床简简治简究。 研自 1997 年至 2000 年任简美布拉斯国内加大院简瘤科主治简～副授～ 博士后简简。自学医学医教2000 年至今在美国 M.D. Anderson 简瘤院及究所任副主任简、副授、博士后简简。医研医教 本人二十年一直事来从癌症简物治简及新抗癌简物的简床治简究。美及加研并与国拿大制简合作厂研制出三简新简型抗癌简物, 其中塔西瓦 (TARCEVA) 已简被美食品简物管国理局批准上市用于治简肺癌; 外简 另两(C424-Maytansinoid 治简简简癌及简力金 治简腺癌胰) 目前正在美及加拿大简行简床国简简治简。本人曾在十次简癌症简上简表演简～ 在几国会国内 外简志上简表简三十余篇简文及简文～且在出版了三本有简癌症防治的简医学医学并国内 著。本人在癌症治简方面的成就曾被外主要 媒包括美简社、 美有简播国内体国广网 (CNN)、 美家播公司 国国广(NBC)、哥简比简播公司 广(CBS)、 中新简社、人民日简、国 健康简、中科技部做简简简。 国 学会会: 简 美癌症究简简、美科简、美中简～中简简。国研会会国学学会会医学会会医学学会会 在简表的文及简著国内献 1,简年,刘I 期及II期睾丸非精原简胞瘤的治简。《外简瘤分》国医学册2,87～1981。 2,简年,刘CT、超简及血管造影在简癌简前分期方面的比简。《外简床放射分声断国医学 册》4,189～1983。 3,简年,简腺癌的淋巴简简简。《外泌尿分》刘清国医学册4,封3～1983。 4, 简年,人白简胞刘a,干简素治简简简胞癌。《外简瘤分》国医学册3,184～1984。 5, 简年,简上腺病简的超简简简。《外简床放射分》刘声断国医学册2,115～1984。 6, 简年,刘CT在简及治简前列腺癌方面的作用。《外简床放射分》断国医学册3, 179～1984。 7,简年,简移性前列腺癌的激素治简和化简的简合简用。《外泌尿分》刘国医学册5, 233～1984。 8, 简年,吸烟膀胱癌简病简系的一简简性究。《外简瘤分》刘与国研国医学册1,50～1985。 9, 简年,尿路造影膀胱简简简简膀胱粘膜病简的效果比简。《外简床放射分刘与断国医学 册》2,118～1985。 10, 简年、简简简,刘32磷体静脉兔简简供白简胞注射简简理简同简皮简移植存活期延简作用。《中简 器官移植》5,54～ 1984。 11, 简年主简,《简用简瘤简床治简手》人民简生出版社～刘册199612, 简年主简,《癌症防治指南》人民简生出版社～刘1995 13, 简年主简,《癌症防治刘200简》天津科技出版社～1998 在外国简表的著作: Xiangdong Liu, Jordan S. Fridman, Qian Wang, Eian Caulder, Gengjie Yang, Maryanne Covington, Changnian Liu, Cindy Marando, Jincong Zhuo, Yanlong Li, Wenqing Yao, Kris Vaddi, Robert C. Newton, Peggy A. Scherle and Steven M. FriedmanSelective Inhibition of ADAM Metalloproteases Blocks HER-2 Extracellular Domain (ECD) Cleavage and Potentiates the Anti-Tumor Effects of Trastuzumab . Cancer Biology & Therapy 5:648-656,2006 Bin-Bing S. Zhou, Michael Peyton, Biao He, Changnian Liu, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 10: 39-50, 2006 Liu, C, Willingham M, Liu J, Gmeiner WH. Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts. Int. J. Oncol. 21: 2400-2407, 2002 Liu CN, Ferdinandi ES, Ely G, Joshi S. Virulizin, a novel immunotherapeutic agent, in treatment of human pancreatic cancer xenografts. Int. J. Oncol. 16: 1234-1240, 2000Liu CN, Ferdinandi ES, Ely G. Virulizin-2gamma, biological response modifier treatment of pancreatic cancer. Drugs of the Future 25:356-359, 2000 Ferdinandi ES, Braun DP, Liu CN, Zee BC, Ely G. Virulizin-A review of its antineoplastic activity. Exp. Opin. Invest. Drugs 8:1721-1735, 1999 Liu CN, Ravi VJ Chari. The development of antibody delivery systems to target cancer with highly potent maytancinoids. Exp. Opin. Invest. Drugs 6:169-172, 1997 Liu CN, Widdison W, Bourret LA, Glodmacher VS, Kedersha N, Ariniello P, Lambert JM, Blatter WA, Chari RV. Eradication of large colon tumor xenografts by targeted delivery of maytansinoid. Pro. Natl, Acad. Sci. USA 93:8618-8623, 1996 Liu CN, O’Connor R, Lambert JM, Blattler WA. Cure of drug-resistant human B-cell lymphoma xenografts by combinations of anti-B4-blocked ricin immunotoxin and chemotherapeutic drugs. Blood 87:3892-3898, 1996 Liu CN, Kimler BF, Evans RG, Morantz RA. Immune adjuvants plus chemotherapy or radiotherapy in the 9L rat brain tumor model. J Neuro-Oncol 15:113-123, 1993Chari RJ, Jackel KA, Bourret LA, Derr SM, Tadayoni BM, Mattocks KM, Shah SA, Liu CN, Blattler WA, Goldmacher VS. Enhancement of selectivity and antitumor efficacy of a CC-1065 analogue through immunoconjugate formation. Cancer Res. 55:4079-4084, 1995O’Connor R, Liu CN, Ferris CA, Teicher BA, Guild BC, Corvi CC, Liu Y, Arceci RJ, Glodmacher VS, Lambert JM, Blattler WA. Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors. Blood 86: 4286-42941, 1995Morantz RA, Kimler BF, Liu CN, Evans RG. Combination of aziridinylbenzoquinone and cis-platinum with radiation therapy in the 9L rat brain tumor model. Int J Radiat Oncol Biol Phys 26:445-450, 1993 Kimler BF, Liu CN, Evans RG, Morantz RA. Effect of pentobarbital on normal brain protection and on the response of 9L rat brain tumor to radiation therapy. J Neurosur 79:577-583, 1993Kimler BF, Liu CN, Evans RG, Morantz RA. Intracerebral chemotherapy in the 9L rat brain tumor model. J Neuro-Oncol 14:191-200, 1992 参国会加简简简及演简 Changnian Liu, Eian Calder, Philip Czerniak, et al. The selective Inhibitor of ADAM metalloproteases INCB3619enhanced efficacy of cytotoxic drugs against human tumor thxenografts. Abstract, 96 AACR Annual Meeting, 2005, Anaheim, CA (submitted). 5FGmeiner WH, Liu J, Liu CN. In vivo efficacy and safety of dU. Clin Cancer Res 7 (suppl): 10 3678-3679, 2001 Tarantolo SR, Kitzan M, Rao A, Liu CN, Kessinger MA, Joshi SS. Therapeutic potentials of human umbilical cord blood cells against human breast cancer cells. Proc Am Assoc Cancer Res 41: 332, 2000 Liu CN, Mao HS, Wang, XJ, Halperin J, Ferdinandi ES, Ely G. Inhibition of tumor growth in treatment of human colon cancer and non-small cell lung cancer xenografts by novel dibenzazepines, NC381 and NC384. Clin Cancer Res 5 (suppl): 3768, 1999 Liu CN, Mao H., Joshi SS, Harris J, Zee B, Ferdinandi ES, Ely G. A novel immunotherapeutic agent for pancreatic cancer: Results of preclinical and clinical trials using Virulizin. Proc Am Assoc Cancer Res 40: 575, 1999 Liu CN, Bourret LA, Derr SM, Widdison WC, Lambert JM, Blatter WA, Chari RV. Cure of human small lung cancer xenografts in SCID mice by a hN901-Maytansinoid conjugate. Proc Am Assoc Cancer Res 38:29, 1997 Liu CN, Widdison W, Bourret LA, Glodmacher VS, Kedersha N, Ariniello P, Lambert JM, Blatter WA, Chari RV. Cure of large colon cancer xenografts by a C242- Maytansinoid conjugate. Proc Am Assoc Cancer Res 37:466, 1996 Liu CN, Tadayoni M, Chari R, Grismore D, Bourret L, Goldmacher V, Ariniello P, Lambert J, Blattler WA. Cure of human colon cancer xenografts by a C242-Maytansinoid conjugate. Proc Am Assoc Cancer Res 36:407, 1995 Liu CN, O’Connor R, Blattler WA, Lambert JM. Cure of drug resistant human B-cell lymphoma xenografts by anti-B4-blocked ricin immunotoxin and chemotherapy. Proc Fifth Intl Congress on Anti-Cancer Chemotherapy, Paris, France January 31-February 3, p193, 1995Liu CN, O’Connor R, Derr S, Shah SA, Blattler WA. Overcoming drug resistance in vivo by anti- B4-blocked ricin immunotoxin against a human B-cell lymphoma. Proc Am Assoc Cancer Res 35: 413, 1994 Liu CN, O’Connor R, Derr S, Shah SA, Blattler WA. Potentiation of chemotherapy by anti-B4-blocked ricin against a human B-cell lymphoma in vitro and in vivo. Blood 82:140a, 1993 Liu CN, Derr SM, Blattler WA, Shah SA. Immunotoxin anti-B4-blocked ricin and chemotherapy in treatment of human B cell lymphoma in SCID mice. Antibody Immunoconjugates Radiopharmaceuticals 6:66, 1993 Liu CN, Sharp JG, Chu S, Crouse DA. Detection of high proliferative potential colony-forming cells (HPP-CFC) in peripheral blood of the mouse. Exp Hematol 18:554, 1990Liu CN, Sharp JG, Ogren FP, Crouse DA. Altered hematopoietic stem and progenitor cell content and tissue distribution in squamous cell carcinoma (KLN205) bearing mice. Proc Am Assoc Cancer Res 31:60, 1990 Liu CN, Ogren FP, Joshi SS, Crouse DA. Scintigraphy and distribution of radioiodinated monoclonal antibody B72.3 in nude mice bearing human tumor xenografts. Proc Am Assoc Cancer Res 30:397, 1989 Liu CN, Sharp JG, Kessinger MA, Ogren FP, Crouse DA. Transplanted squamous cell carcinoma (KLN205) increased the number of circulating stem cells in the mouse. Leukemia 3:765, 1989 简的简目,制及简新抗癌简物 研仿(简如利金等简)治简腺癌、肺癌及简直简癌胰